BlackRock Japan’s Regenxbio RGNX Stock Holding History

BlackRock Japan’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-550	Closed	-$8K	–	1357
2016 Q3	$8K	Sell	550 -107	-16%	-$1.18K	﹤0.01%	1226
2016 Q2	$5K	Buy	+657	New	+$7.29K	﹤0.01%	1342

Other funds holding RGNX

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock Japan's RGNX Position: Q4 2016 in Review

BlackRock Japan sold out of Regenxbio (RGNX) in Q4 2016, closing a stake of 550 shares — an estimated $8K sold.

BlackRock Japan first reported a position in RGNX in Q2 2016 and held it in 2 quarters. The position peaked at $8K in Q3 2016. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

BlackRock Japan reported no remaining Regenxbio position as of Q4 2016 after selling out during the quarter.
BlackRock Japan sold 550 Regenxbio shares in Q4 2016, an estimated $8K.
BlackRock Japan first reported a position in Regenxbio in Q2 2016 and held it in 2 quarters.
BlackRock Japan's Regenxbio position peaked at $8K in Q3 2016.
78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.